Diagnostic imaging, including a dopamine transporter (DAT) scan and 123I-meta-iodobenzylguanidine imaging, showed reduced uptake, leading to a diagnosis of DLB rather than delirium [155]. The gene discussed is SLC6A3; the disease is delirium.